NasdaqGS:MORNCapital Markets
How Morningstar’s New CME Derivatives Licensing Deal (MORN) Has Changed Its Investment Story
CME Group recently announced a multi-year exclusive licensing agreement with Morningstar to launch derivatives based on Morningstar equity index benchmarks that underpin over US$3.00 trillion in linked assets.
This partnership expands the ways investors can use Morningstar’s indexes in risk management and trading, potentially deepening the firm’s role in global markets.
We’ll now examine how this new derivatives licensing agreement with CME Group could influence Morningstar’s investment...